The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Oliver Tracie since 2023.
This trader's CIK number is 1935706.
At the time of last reporting, Oliver Tracie was the Chief Commercial Officer of Arrowhead Pharmaceuticals, Inc.. (stock ticker symbol ARWR).
Also see all insider trading activities at Arrowhead Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ARWR | 0 | $0 | 9,468 | $239,987 | 0 | $0 |
| 2023 | ARWR | 0 | $0 | 8,925 | $315,141 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-07-02 | ARWR | Sale | 9,394 | 25.28 | 237,480 |
| 2024-01-05 | ARWR | Sale | 74 | 33.89 | 2,507 |
| 2023-07-03 | ARWR | Sale | 8,925 | 35.31 | 315,141 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oliver Tracie (Chief Commercial Officer of Arrowhead Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.